Investor Update
Basel, 23 February 2011
Xeloda approved in Japan for Additional Indication of Advanced or Recurrent Gastric Cancer, which is Not Amenable to Curative Resection
Dear Investor,
Please find attached a press release by Chugai:
http://www.roche.com/inv-update-2011-02-23-annex.pdf
Do not hesitate to contact us for any further questions.